Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pseudovitelliform maculopathy secondary to BRAF and MEK inhibitors in a patient with metastasic melanoma.

Journal of biological regulators and homeostatic agents·2019
Same author

Current trends in the chemotherapy of colorectal cancer.

Current medicinal chemistry·2012
Same author

Expression of immune modulator cytokines in human fulminant amoebic colitis.

Parasite immunology·2009
Same author

Trophozoites of Entamoeba histolytica express a CD59-like molecule in human colon.

Parasitology research·2008
Same author

Immunohistochemical characterization of human fulminant amoebic colitis.

Parasite immunology·2007
Same author

Cisplatin plus continuous infusion vinorelbine for the treatment of advanced non-small cell lung cancer: a phase I-II study.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2006

Related Experiment Video

Updated: Apr 26, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.3K

Nanoparticles in melanoma.

M A Berciano-Guerrero, A Montesa-Pino, G Castaneda-Penalvo

  • 1Medical Oncology Section, Hospital Regional Universitario Carlos Haya, Malaga, Avda. Carlos Haya s/n; 29010 Malaga, Spain. migueberci@gmail.com.

Current Medicinal Chemistry
|July 22, 2014
PubMed
Summary
This summary is machine-generated.

Nanoparticles offer new hope for treating metastatic malignant melanoma, a leading cause of cancer death in young adults. This review standardizes nanoparticle classification and updates research on their clinical use in melanoma treatment.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K

Related Experiment Videos

Last Updated: Apr 26, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

7.3K
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.2K

Area of Science:

  • Oncology
  • Nanotechnology
  • Materials Science

Background:

  • Malignant melanoma is a significant cause of cancer mortality, particularly in younger populations.
  • Limited treatment options were available for metastatic melanoma until recently.
  • Advances include immunotherapy, tyrosine kinase inhibitors, and nanoparticle-based therapies.

Purpose of the Study:

  • To propose a standardized classification system for nanoparticles based on chemical properties.
  • To provide an updated overview of clinical research involving nanoparticles in melanoma treatment.

Main Methods:

  • Literature review of existing research on nanoparticle classification.
  • Synthesis of current clinical trial data on nanoparticle applications in melanoma.

Main Results:

  • Identified key chemical characteristics for nanoparticle categorization.
  • Summarized the efficacy and safety profiles of various nanoparticles in melanoma treatment.

Conclusions:

  • A standardized classification will aid in understanding and developing nanoparticle therapies.
  • Nanoparticles represent a promising frontier in the management of metastatic malignant melanoma.